NetworkNewsBreaks – FAVO Capital (OTC: FAVO) App
Post# of 35

FAVO Capital (OTC: FAVO), a diversified financial company with operations in financial services and real estate, announced the appointment of Dr. Wael Barsoum to its board of directors as an independent director. Barsoum, former president and CEO of Cleveland Clinic Florida and current president and chief transformation officer at Healthcare Outcomes Performance Company, brings decades of leadership in healthcare innovation, governance, and organizational growth. “Wael’s appointment reflects our commitment to building a board with the independence, depth, and experience to guide FAVO’s next chapter,” said Shaun Quin, president of FAVO Capital.
NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://nnw.fm/FAVO
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

